Physician profile
Christopher J Corey
NPI 1306815071
$3,094.68
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $327 · 2021: $603 · 2022: $272 · 2023: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $905.64 | 2019-2021 | |
| Silk Road Medical, INC. | $529.09 | 2020-2022 | |
| Endologix LLC | $354.86 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $142.19 | 2019-2021 | |
| Veryan Medical Incorporated | $126.90 | 2021 | |
| Smith+Nephew, INC. | $98.66 | 2019 | |
| Cardiovascular Systems INC. | $71.21 | 2019 | |
| Shockwave Medical, INC | $70.91 | 2022 | |
| Boston Scientific Corporation | $48.96 | 2022 | |
| Tactile Systems Technology INC | $45.51 | 2020 | |
| Getinge USA Sales, LLC | $27.47 | 2020 | |
| Aroa Biosurgery Incorporated | $18.27 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Corey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.